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Differentiation ofCampylobacter fetus intoC. fetus subsp. fetus (Cff) andC. fetus subsp. venerealis
(Cfv) is important for both clinical and economic reasons. In the past, several molecular typing
methods have been used for differentiation, including amplified fragment length polymorphism
(AFLP). In this study, AFLP was employed to identifyC. fetus subspecies specific markers that can
serve as a basis for design of novel PCR primer sets for Cfv. Four groups of C. fetus strains with
different phenotypic or genotypic traitswere examined by AFLP using 22differentDdeI/MboI primer
combinations. Specific AFLP fragments were deduced and sequenced resulting in 41 sequences.
Based on the obtained sequences, five potential subspecies-specific PCR assays were developed.
Extensive evaluation of the five selected PCRs with a set of 65 diverse C. fetus strains identified
primer setCfC05 as subspeciesCfv-specific. This newly developedPCR is fully consistent with the
AFLP subspecies differentiation results. The data indicate AFLP as a powerful tool for comparing
closely related genomes and for exploiting this information to develop a specific PCRwith extensive
typing potential.
INTRODUCTION
The species Campylobacter fetus, a micro-aerophilic, Gram-
negative, curve-shaped bacterium, can be classified into two
subspecies,C. fetus subsp. venerealis (Cfv) andC. fetus subsp.
fetus (Cff) (Ve´ron & Chatelain, 1973). Cfv causes bovine
genital campylobacteriosis (Florent, 1959; Ve´ron & Chate-
lain, 1973) and is considered a host-restricted pathogen. Its
presence in the genital tract of cattle is associated with
abortion and infertility, and it is therefore of economic
importance. Cff is neither host- nor habitat-restricted;
several animal species can carry Cff in the intestinal tract
(Florent, 1959; Ve´ron & Chatelain, 1973). Cff is associated
with abortion in sheep, but generally causes less severe
clinical symptoms in cattle compared to Cfv.
As some countries have eradicated Cfv from their cattle
population, discrimination of both subspecies of C. fetus is
crucial for veterinary control programmes. Subspecies dif-
ferentiation is also of economic importance since Cfv-nega-
tive status of the animals is required by law for both the
artificial insemination and embryo transfer industries
(Anonymous, 2000; Wagenaar & Van Bergen, 2004).
The phenotypic test prescribed by the World Organisation
for Animal Health (OIE) to differentiate the two C. fetus
subspecies is the glycine-tolerance test (Wagenaar & Van
Bergen, 2004). This test is based on the growth of Cff but not
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The GenBank accession number for the target gene sequence of PCR Cf
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Cfv in 1% glycine. However, the reproducibility of the assay
is poor and the test can give ambiguous results (Harvey &
Greenwood, 1983; On, 1996; On&Harrington, 2001). Other
phenotypic tests, such as selenite reduction and antibiotic
susceptibility, are only indicative and do not completely
discriminate between the subspecies (On, 1996; Vandamme,
2000). Several molecular typing methods have been applied
to discriminate the two subspecies, including PFGE (On &
Harrington, 2001), amplified fragment length polymorph-
ism (AFLP) (Wagenaar et al., 2001) and PCR (Hum et al.,
1997; Wang et al., 2002). While numerical analysis of PFGE-
DNA profiles is a valuable tool for differentiating C. fetus
subspecies, it is time-consuming, difficult to interpret and
therefore impractical for routine use. Similarly, the AFLP
method is useful for differentiation of C. fetus subspecies
(Wagenaar et al., 2001) but it is laborious, time-consuming
and not available in every diagnostic laboratory. PCR is fast
and easily applicable, but the currently available assays have
been reported to give erroneous results (Hum et al., 1997;
Wagenaar et al., 2001) or have only been tested for a very
limited set ofC. fetus strains (Wang et al., 2002). In the search
for a robust, reliable and easy-to-use diagnostic PCR,we used
the novel approach of DNA sequencing ofC. fetus subspecies
specific markers identified by AFLP to develop a PCR-based
discriminative assay.
METHODS
Strains, DNA and typing methods. Sixty-five C. fetus strains (Table
1), comprising 62 field isolates and three reference strains, were grown
under microaerobic conditions (6% O2, 7% CO2, 7% H2, 80% N2;
Anoxomat, Mart Microbiology) on heart-infusion agar supplemented
with 5% sheep blood (Biotrading) for 3 days. All strains were typed by
the subspecies-specific PCRs developed by Hum et al. (1997) andWang
et al. (2002) and by the HindIII/HhaI AFLP as previously described by
Wagenaar et al. (2001). Strains used for the selection pools 1–4 (Table 1)
were also tested for the ability to tolerate 1% glycine (Table 2)
(Wagenaar et al., 2001).
Chromosomal DNA of all strains was isolated with the Puregene kit
(Gentra systems; BIOzym) and diluted to a final concentration of 40–50
ng l1 for each pool. For PCR on individual strains, the DNA of each
strain was diluted to a concentration of 1–10 ng l1. PCR was also
performed on cruder samples, i.e. on DNA prepared by 20% Chelex-
100 extraction (Engberg et al., 2000), and on cell suspensions (OD600 ¼
0.1 in SuperQ water).
Group selection and MboI/DdeI AFLP. Based on results of AFLP
genotyping and biochemical properties of the strains, four groups were
identified (Table 2): group 1, Cff; group 2, Cff that differed from the first
group in oneHindIII/HhaI AFLP fragment; group 3, Cfv; and group 4,
Cff strains that were biochemically aberrant compared to groups 1 and 2
[no growth in the glycine test indicating Cfv, whereas PCR (Hum et al.,
1997) and AFLP (Wagenaar et al., 2001) indicated Cff]. From each
identified group, two to four strains were selected fromwhich DNAwas
pooled (indicated with pool number in Table 1). Each of theDNApools
was used as template in the AFLP analysis with restriction enzyme
combination MboI/DdeI.
Identification of C. fetus subspecies specific markers. Pooled
DNA of the four C. fetus groups was examined by AFLP using the
restriction enzyme combinationMboI/DdeI. This enzyme combination
was chosen based on the AFLPinSilico band pattern for the sequenced
Campylobacter jejuni NCTC strain 11168 using the REcomb program
(Reijans et al., 2003). AFLPinSilico mimics AFLP experiments and
produces virtual fingerprints that enable the identification of fragments
based on their length and the choice of selective nucleotides (Rombauts
et al., 2003). Since the genome ofC. fetus is not in the public domain, no
information about suitable restriction enzymes for AFLP of C. fetuswas
available when this study was conducted. As C. jejuni is its nearest
genome-sequenced relative, AFLPinSilico was done using this strain.
AFLP was performed essentially as described by Vos et al. (1995) and
Van den Braak et al. (2004). Briefly, chromosomal DNA of each group
was digested with restriction enzymes MboI and DdeI (Roche) and
specific MboI and DdeI adaptors were ligated (MboI: forward 59-
CTCGTAGACTGCGTACC-39, reverse 59-GATCGGTACGCAGTC
TAC-39; and DdeI: forward 59-GACGATGAGTCCTGAG-39, reverse
59-TNACTCAGGACTCAT-39). Pre-amplification was performed as
described by Vos et al. (1995), using primers without selective
nucleotides. In the following selective amplification, samples were
amplified using a 33P-labelled MboI primer containing one selective
nucleotide, and a DdeI primer containing two selective nucleotides. In
total, 22 different primer combinations were tested. Amplicons were
run on 5% denaturing polyacrylamide gels and fingerprints were
visualized by phosphor imaging and screened automatically using AFLP
QuantarPro software (Keygene Products). Fragments only commonly
present in groups 1, 2 and 4 and absent in group 3 were potentially
specific for Cff. Fragments only present in group 3 and absent in the
other groups were potentially specific for Cfv. These candidate
fragments were excised and re-amplified using AFLP primers without
selective nucleotides. Successfully amplified products were sequenced
on a capillary sequencer and analysed using the Basic Local Alignment
Search Tool (BLASTX and BLASTN search) (http://www.ncbi.nlm.nih.
gov/blast).
Development of subspecies-specific PCRs. For all 41 properly
sequenced fragments, primer sets were developed to enable specific
amplification of the fragments. Each set of primers was examined for its
subspecies specificity by pre-screening the set with DNA from a well-
defined panel of sevenCff and sevenCfv strains, indicated inTable 1 by †
(Cff) and k (Cfv). Primer sets yielding a subspecies-specific fragment
were used with DNA of all strains shown in Table 1. PCRwas performed
using the following conditions. Each 50 l of reaction mixture con-
tained 32.7 l SuperQ water, 5 l 103 PCR buffer II (Applied
Biosystems), 3 l 25 mM MgCl2 (Applied Biosystems), 0.3 l 5 U l1
Taq polymerase (Applied Biosystems), 5 l 2 mM dNTP (Amersham
Biosciences), 1 l 25 pmol l1 forward primer (Invitrogen, Life-
Technologies), 1 l 25 pmol l1 reverse primer and 2 l chromosomal
DNA solution (1–10 ng l1). The PCR using primer set Cf C05
(forward, 59-ATGATAAGATATATTTGTATCAG-39; reverse, 59-GAT
GAAGAATATTACAAGATAAT-39) was performed as described above,
except that 0.25 l 5 U l1 SuperTaq polymerase (HT Biotechnology)
and the supplied 103 buffer, including MgCl2, were used. All PCR
reactionswere performed in aPerkin Elmer 9700 thermocycler using the
following conditions: 5 min incubation at 95 8C, 30 cycles of 1 min at
94 8C, 1 min at the calculated annealing temperature, and 2 min at
72 8C. Reactions were completed by extension at 72 8C for 10 min. The
five selected PCRs (Cf B01, Cf B03, Cf B06, Cf C02 and Cf C05) with
diagnostic potential were tested at both higher (+1 8C to +5 8C) and
lower (1 8C to 5 8C) annealing temperatures to assess the effect of
temperature on the specificity of the PCR, and to reduce background.
Higher annealing temperatures showing less background and identify-
ing the same strains to be positive as the calculated annealing
temperatures were selected. PCR Cf C05 had an optimum annealing
temperature at 54 8C. All PCRs using the selected primer sets were
performed in duplicate. PCRs that proved useful on chromosomalDNA
were tested for their specificity on DNA extracted using the Chelex
method and on cell suspensions. All PCR products exceeding 100 bp
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Table 1. Comparison of subspecies differentiation results of AFLP and PCRs
F, Identified as Campylobacter fetus subsp. fetus; V, identified as Campylobacter fetus subsp. venerealis; , no specific PCR product. T, type strain.
Strain AFLP PCR Source Country Supplier
Hum
et al.
(1997)
Wang
et al.
(2002)
Cf C05
378/5 F F F  Bovine Belgium J. Godfroid, Veterinary and Agrochemical Research
Centre, Brussels
4114 F V F  Human Belgium J. P. Butzler, University of Brussels
F128 F F F  Human Belgium J. P. Butzler, University of Brussels
L249093 F F   Human Spain P. Idigoras, Hospital Donostia, San Sebastia´n
ATCC 27374T*† F F F  Ovine France
F8135 F F F  Human Germany W. Kalka-Moll, University of Cologne
m*† F F F  Bovine Netherlands Animal Sciences Group, Lelystad
110800 1-2 F V   Bovine Netherlands Animal Sciences Group, Lelystad
938230 F F F  Bovine Netherlands M. Koene & I. Visser, Animal Health Service, Deventer
5,5,42 F F   Ovine Netherlands M. Koene & I. Visser, Animal Health Service, Deventer
501340 F F F  Bovine Netherlands M. Koene & I. Visser, Animal Health Service, Deventer
601 F F   Ovine Netherlands M. Koene & I. Visser, Animal Health Service, Deventer
Ru-13826 F F F  Bovine Netherlands M. Koene & I. Visser, Animal Health Service, Deventer
Ru-17722-2 small F F   Bovine Netherlands M. Koene & I. Visser, Animal Health Service, Deventer
Ru-9516-18 F F F  Bovine Netherlands M. Koene & I. Visser, Animal Health Service, Deventer
Sz-1074 F F F  Ovine Netherlands M. Koene & I. Visser, Animal Health Service, Deventer
0111-23289 F V F  Human Netherlands W. Ang, Erasmus Medical Center Rotterdam
10†‡ F F F  ? South Africa M. Hinton, Onderstepoort Veterinary Institute
135‡ F F F  ? South Africa M. Hinton, Onderstepoort Veterinary Institute
Cfv-za‡ F F F  ? South Africa M. Hinton, Onderstepoort Veterinary Institute
8 F F F  ? South Africa M. Hinton, Onderstepoort Veterinary Institute
136 F F   ? South Africa M. Hinton, Onderstepoort Veterinary Institute
248,1 F F F  ? South Africa M. Hinton, Onderstepoort Veterinary Institute
5396/7 F F F  ? South Africa M. Hinton, Onderstepoort Veterinary Institute
Zaf1 F F F  Bovine South Africa M. Hinton, Onderstepoort Veterinary Institute
122*† F F   Ovine Turkey L. Guler, Veteriner Kontrol ve Aras¸tirma Enstitu¨su¨,
Konyn
68 F F F  Ovine Turkey L. Guler, Veteriner Kontrol ve Aras¸tirma Enstitu¨su¨,
Konyn
74 F F   Ovine Turkey L. Guler, Veteriner Kontrol ve Aras¸tirma Enstitu¨su¨,
Konyn
V51/99†§ F F   Bovine UK D. Newell & M. Toszeghy, Veterinary Laboratories
Agency, Weybridge
98/v444†§ F F   Bovine UK D. Newell & M. Toszeghy, Veterinary Laboratories
Agency, Weybridge
XV-98*† F F   Ovine UK D. Newell & M. Toszeghy, Veterinary Laboratories
Agency, Weybridge
0194-98 F F   Ovine UK D. Newell & M. Toszeghy, Veterinary Laboratories
Agency, Weybridge
98/v156 F F   Bovine UK D. Newell & M. Toszeghy, Veterinary Laboratories
Agency, Weybridge
98/v445 F V F  Bovine UK D. Newell & M. Toszeghy, Veterinary Laboratories
Agency, Weybridge
DC 20C F F F  Bovine UK J. Corry, University of Bristol
C036271 F F F  Human UK J. Frost, Health Protection Agency, London
C036959 F F   Human UK J. Frost, Health Protection Agency, London
3051 F F F  Bovine USA I. Wesley, National Animal Disease Center, Ames
cont.
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Table 1. cont.
Strain AFLP PCR Source Country Supplier
Hum
et al.
(1997)
Wang
et al.
(2002)
Cf C05
3290 F F F  Ovine USA I. Wesley, National Animal Disease Center, Ames
3293 F F   Bovine USA I. Wesley, National Animal Disease Center, Ames
3754 F F F  Human USA I. Wesley, National Animal Disease Center, Ames
6877 F V F  Bovine USA I. Wesley, National Animal Disease Center, Ames
3286 (small) F F F  Ovine USA I. Wesley, National Animal Disease Center, Ames
3292 F F F  Bovine USA I. Wesley, National Animal Disease Center, Ames
87-364 F F F  Equine USA L. Schroeder-Tucker, National Veterinary Services
Laboratories, Ames
87-72 F V F  Bovine USA L. Schroeder-Tucker, National Veterinary Services
Laboratories, Ames
87-742-1 F V F  Bovine USA L. Schroeder-Tucker, National Veterinary Services
Laboratories, Ames
97-365-1 F F F  Bovine USA L. Schroeder-Tucker, National Veterinary Services
Laboratories, Ames
82-40 F F F  Human USA M. Blaser & Z. Tu, University of New York
84-104 F F F  Monkey USA M. Blaser & Z. Tu, University of New York
84-91 F F F  Human USA M. Blaser & Z. Tu, University of New York
D223 F F F  Human USA P. Fields, Centers for Disease Control and Prevention,
Atlanta
D5605 F F F  Human USA P. Fields, Centers for Disease Control and Prevention,
Atlanta
LMG 6570 V V  V Bovine Belgium
511k V V F V Bovine Hungary J. Varga, Faculty of Veterinary Science, Budapest
18156k V V  V Bovine Netherlands Animal Sciences Group, Lelystad
5.5.21k} V V  V Bovine Netherlands M. Koene & I. Visser, Animal Health Service, Deventer
ATCC 19438T k} V V  V Bovine UK
97/v549k} V V  V Bovine UK D. Newell & M. Toszeghy, Veterinary Laboratories
Agency, Weybridge
3288 V V  V Bovine USA I. Wesley, National Animal Disease Center, Ames
3295 V V  V Human USA I. Wesley, National Animal Disease Center, Ames
89-083 V V  V Bovine USA L. Schroeder-Tucker, National Veterinary Services
Laboratories, Ames
90-152 V F  V Bovine USA L. Schroeder-Tucker, National Veterinary Services
Laboratories, Ames
84-112k V V  V Bovine USA M. Blaser & Z. Tu, University of New York
99-257k V V  V Human USA M. Blaser & Z. Tu, University of New York
*Cff DNA used for pool 2.
†Cff DNA used for pre-screening of the primer sets.
‡Cff DNA used for pool 4.
§Cff DNA used for pool 1.
kCfv DNA used for pre-screening of the primer sets.
}Cfv DNA used for pool 3.
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were run on a 1.5% agarose gel and PCR products smaller than 100 bp
were run on a 3% agarose gel. PCR Cf C05 revealed a PCR product of
54 bp. PCR products were visualized by ethidium bromide staining.
RESULTS
Identification of C. fetus subspecies specific
markers
Analysis of the C. fetus subspecies specific region in the
HindIII/HhaI AFLP (Wagenaar et al., 2001) revealed three
distinct genotype groups. In a search for subspecies-specific
markers, these groups and a fourth group that showed an
aberrant reaction in the glycine test were subjected to AFLP
with 22 different MboI/DdeI primer combinations. This
yielded 1161 fragments that were common to all four groups,
and 274 fragments (markers) that were specific for one of
each of the four groups. Thirteen markers appeared to be
shared by groups 1, 2 and 4, and were considered Cff-specific
(Table 3). Fifty-nine Cfv-specific AFLP markers were typical
for group 3 (Table 3). All 72 (13 Cff + 59 Cfv) identified
markers were excised from the AFLP gel, re-amplified by
PCR, and sequenced. This yielded 41 (5 Cff + 36 Cfv) out of
72 potential sequences.
Development of subspecies-specific PCRs
To assess the use of the identified sequences for subspecies
identification, PCR primer sets were designed for all 41 (5 Cff
+ 36 Cfv) sequences obtained and tested on a subset of C.
fetus strains (Table 1, strains indicated by † or k). From the
five selected Cff primer combinations, none were specific for
Cff strains (Table 3). Yet, five of 41 primer combinations (Cf
B01, Cf B03, Cf B06, CfC02 andCfC05) yielded reproducible
PCR products for the specific identification of Cfv (Table 3).
The diagnostic potential of these five Cfv-specific PCRs was
further assessed with a set of 65 C. fetus strains, including
three reference strains and 62 very diverse field isolates (Table
1). Strains originating from the same outbreaks displayed the
same outcome for all individual PCRs (data not shown).
Comparison of the newly developed diagnostic
PCRs with existing methods
To position the novel diagnostic PCRwith existingAFLP and
PCR assays, 65 strains were analysed with the different typing
methods. In those assays, 24 out of 65 strains yielded a
different classification in the various tests (Table 1). Refer-
ence strains ATCC 27374T (¼NCTC 10842T), ATCC 19438T
(¼ NCTC 10354T) and LMG 6570 (¼ CCUG 7477) gave
similar results in all assays. With the other strains the results
of the Cff-specific PCR described by Wang et al. (2002) gave
the most variable results compared to all other tests. For this
reason, this PCR method was not used further in the
comparative study.
Further comparison of the other assays showed that the
results of the newly developed primer sets Cf B01, Cf B03, Cf
C02 and Cf B06 approached either those of the PCR
described by Hum et al. (1997) or those of the AFLP. Primer
sets Cf B01, Cf B03, Cf C02 and Cf B06 showed, respectively,
two, four, three and nine discrepancies with the results of the
PCR assay of Hum et al. (1997), and, respectively, eight, six,
seven and one differences compared to the HindIII/HhaI
AFLP. However, the results with the primer set Cf C05 were
fully consistent (65/65) with AFLP, while eight of these
strains yielded different results with the PCR of Hum et al.
(1997).
As the PCRs with the primer set Cf C05 appeared to better
reflect AFLP results, the use of this PCR was assessed with C.
fetus target DNA extracted by Chelex and by cell suspensions
Table 3. Subspecies designation results based on AFLP identified specific markers
Specific for: Specific for pool: No. of unique markers No. of sequences
obtained
No. of potential
specific PCRs
No. of specific PCRs that
correlate with AFLP
Cff 1, 2, 4 13 5 0 0
Cfv 3 59 36 5 1
Total 72 41 5 1
Table 2. The four identified groups of C. fetus strains used for DdeI/MboI AFLP analysis
Group Properties Biochemical
(1% glycine-
tolerance test)
PCR (Hum
et al.,
1997)
AFLP
(Wagenaar
et al.,
2001)
1 Cff Cff Cff Cff
2 Cff, differing from pool 1 in one HindIII/HhaI fragment Cff Cff Cff
3 Cfv Cfv Cfv Cfv
4 Cff, differing from pool 1 by being negative in the glycine assay Cfv Cff Cff
C. fetus specific markers identified by AFLP
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rather than purified chromosomal DNA. All three DNA
isolation methods yielded the same outcome for all indivi-
dual strains resulting in acceptable PCR products (data not
shown).
Sequence analysis of the subspecies-specificAFLP
fragments
To gain more information about the nature of subspecies-
specific genetic markers, the respective fragments were
further analysed. All fragments amplified by primer sets Cf
B01, Cf B03, Cf B06, Cf C02 and Cf C05 appeared to carry an
open reading frame. BLAST analysis using publicly available
databases, however, yielded no similarities with sequences
present in the database. Furthermore, alignment of the DNA
sequences of all five PCR products revealed no sequence
similarities among the various sequences or with the Cfv-
specific fragment amplified in the PCR by Hum et al. (1997).
As the PCRCf C05was shown to be useful for differentiation,
the target gene sequence was submitted to GenBank and
given the accession number DQ146479.
DISCUSSION
AFLP fingerprinting indicates that the genetic diversity of C.
fetus is very limited. This is in contrast with other Campy-
lobacter species, including C. jejuni, Campylobacter coli,
Campylobacter lari, Campylobacter upsaliensis and its closest
taxonomic relative Campylobacter hyointestinalis (Roop et
al., 1984), which show more diversity in AFLP patterns
within the species (Duim et al., 2001). The close relatedness
of C. fetus is also apparent from the similar 16S rRNA gene
sequences in the different subspecies (On & Harrington,
2001; Wesley et al., 1991), and the limited phenotype
diversity. Despite these limited differences, initially classifi-
cation into the two subspecies was done based on clinical
presentation and the 1% glycine-tolerance test; Cfv is
venereally transmitted and causes infertility exclusively in
cattle, whereas Cff is orally transmitted, inducing abortion in
sheep and cattle, and rarely septicaemia in humans (Garcia et
al., 1983; Wesley et al., 1991).
At this time, only one assay is accepted by the OIE to
discriminate between the two subspecies. Unfortunately, the
reproducibility of this assay is poor. This is at least partially
due to the sometimes slow and poor growth of C. fetus
isolates. Whether this poor reproducibility reflects genetic
differences is unclear and may await unravelling of the
molecular basis underlying the glycine-tolerance test. An
additional problemwith the glycine-tolerance test is that this
phenotype can be transferred between strains by phage-
mediated transduction (Chang &Ogg, 1971). Thismakes the
assays less attractive for subspecies differentiation purposes.
Reliable discrimination of the C. fetus subspecies is of
veterinary importance as eradication programmes have been
put in place in several countries. Due to the serious
reproductive problems caused by Cfv, countries must report
the presence of the causative agent of bovine genital
campylobacteriosis (BGC) once diagnosed. Eradication pro-
grammes are fully dependent on the correct identification of
the subspecies. More robust and easy-to-use discriminatory
assays would facilitate the control of BGC. Several molecular
tests have been evaluated as alternatives for the glycine test
(Hum et al., 1997; On & Harrington, 2001; Wagenaar et al.,
2001;Wang et al., 2002). Subspecies-specific PCRs have been
described (Hum et al., 1997;Wang et al., 2002) but have been
found to give erroneous results (Hum et al., 1997; Wagenaar
et al., 2001). Development of new, more reliable, easy-to-
perform tests is indispensable, and amultiplex PCR identify-
ing a specific fragment for each subspecies would be a great
asset. Due to the lack of the entire genome sequence of both
subspecies, a genomic subtraction technique (Schober et al.,
2001) which has been useful for identification of differences
between strains (Winstanley, 2002) may be a valuable tool to
detect genetic differences. In the present study, we used the
power of the AFLP technique to identify differences among
closely related genomes (Van den Braak et al., 2004) to
successfully design a rapid PCRmethod for differentiation of
C. fetus subspecies.
The first step towards the identification of subspecies-unique
DNA fragments was the use of the appropriate restriction
enzyme combinations in the AFLP.MboI/DdeI AFLP yielded
72 specific markers, including 59 for Cfv and 13 for Cff. The
lower number of identified Cff-specific markers was prob-
ably due to the fact that the Cff-specific fragments must be
shared by three different Cff groups, compared to one group
for Cfv. AFLP differences may arise from large or minor
genetic differences as well as from single point-mutations,
which thus may cause false results. Although diagnostic PCR
assays based on single nucleotide differences have been
described (Misawa et al., 1998), larger sequence differences
are likely to give more reliable results. For 41 of the 72 DNA
fragments sequence information was obtained each of which
had the potential to serve as a basis for development of
subspecies-specific PCRs.
A rather low yield of subspecies-specific markers compared
to the observed differences inMboI/DdeI AFLPwas apparent.
From the 41 PCR primer sets that were designed on the basis
of the obtained specific sequences only five showed sub-
species specificity towards the seven Cff and seven Cfv
screening strains. This rather low yield may be explained by
heterogeneity in the targeted sequence in different isolates.
Furthermore, for each sequence only one primer set was
developed. As a result of unsuitable primer sets, initially
promising sequencesmight have been discarded, presumably
reducing the number of final potential candidates. Another
reason that these primer sets appeared nonspecific could be
assigned to weak fragments, which were regarded negative in
theMboI/DdeI AFLP, resulting in selection of false candidate
markers. A further reduction from the five potential primer
sets Cf B01, Cf B03, Cf B06, Cf C02 andCfC05 to the oneCfv-
specific primer set Cf C05 was obtained when evaluation of
the primer sets used amuch larger set of different strains than
that screened in the initial selection of specific fragments.
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Akey part of our studywas the evaluation of the usefulness of
novel PCRs in the classification of a large number of field
isolates. This analysis is complex, as the existing methods to
distinguish Cfv and Cff, such as the glycine-tolerance test, are
not optimal. Comparison of the results of AFLP, previously
described PCR methods (Hum et al., 1997; Wang et al.,
2002), and the newly developed PCRs yielded similar results
when reference strains were used.With the diverse set of field
strains, however, differences between the methods became
apparent, indicating considerable strain diversity for the
genetic markers used in the various assays. Yet, in our hands,
the PCR with the primer combination Cf C05 yielded
identical subspecies differentiation to the AFLP, which is
considered a very discriminatory technique. Positive results
were obtained with chromosomal DNA as well as with crude
extracts, indicating the robustness of the assay. These data
indicate that the Cf C05-based PCR is an important asset in
C. fetus subspecies differentiation. For future diagnostics, a
combination of an existing species-specific PCR and the Cf
C05PCR for subspecies discriminationmay be optimal forC.
fetus diagnostics.
The identification of subspecies-specific DNA fragments
may provide important information about differences in
virulence properties. We found no similarities for the
obtained subspecies-specific sequences with proteins in the
databases. Apparently, the sequences onwhich the developed
PCRs were based have not previously been reported or
identified in other bacteria. This could indicate that the
new Cfv-specific PCRCf C05 can be used for development of
a diagnostic assay in which samples can be tested in a
relatively high background of other bacteria.
New Cff-specific markers remained unidentified, and erro-
neous results were obtainedwith the PCR described byWang
et al. (2002). Therefore, attempts to characterize new Cff-
specific markers by this or other molecular methods seem
worthwhile. In this context it should be noted that only 22
out of the possible 64 (+1, +2) primer combinations have
been used in the AFLP screening. In addition, other restric-
tion enzyme combinations might yield a larger pool of
putative specific markers to be tested.
Finally, it should be noted that our successful approach of
using AFLP to identify specific markers adds a new dimen-
sion to this technique that may enhance the identification of
future diagnostic targets as well as virulence genes.
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